Search research articles
Contact Us
Filters
Showing results (221-230 of 255) with videos related to
Page
of 26
Sort By:
Kardiologia Polska
|
January 5, 2016
[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Giornale Italiano Di Cardiologia (2006)
|
November 22, 2016
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
American Heart Journal
|
December 13, 2006
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial
Harvey D White, Neal S Kleiman, Kenneth W Mahaffey, et al.
Revista Espanola De Cardiologia (English Ed.)
|
December 18, 2015
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
European Heart Journal
|
August 31, 2015
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Heart (British Cardiac Society)
|
January 17, 2025
Transitioning to high-sensitivity troponin: 1-year mortality outcomes in patients with suspected acute coronary syndrome presenting to emergency departments
Siobhan Hickling, Frank M Sanfilippo, Louise Cullen, et al.
American Heart Journal
|
February 12, 2026
Design and rationale of A Multicenter Paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock - The PANDA trial
Jason E Bloom, Jocasta Ball, Daniel Okyere, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
December 20, 2019
The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendations for Assessment of Suspected Acute Coronary Syndrome Using High-Sensitivity Cardiac Troponin T in the Emergency Department
Wei Chieh Jack Tan, Kenji Inoue, Laila AbdelWareth, et al.
The American Journal of Cardiology
|
April 28, 2004
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)
A Michael Lincoff, John A Bittl, Neal S Kleiman, et al.
The Medical Journal of Australia
|
August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement
Sarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 255) with videos related to
Sort By:
Page
of 26
Kardiologia Polska
|
January 5, 2016
[2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Giornale Italiano Di Cardiologia (2006)
|
November 22, 2016
[2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)]
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
American Heart Journal
|
December 13, 2006
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial
Harvey D White, Neal S Kleiman, Kenneth W Mahaffey, et al.
Revista Espanola De Cardiologia (English Ed.)
|
December 18, 2015
2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
European Heart Journal
|
August 31, 2015
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi, Carlo Patrono, Jean-Philippe Collet, et al.
Heart (British Cardiac Society)
|
January 17, 2025
Transitioning to high-sensitivity troponin: 1-year mortality outcomes in patients with suspected acute coronary syndrome presenting to emergency departments
Siobhan Hickling, Frank M Sanfilippo, Louise Cullen, et al.
American Heart Journal
|
February 12, 2026
Design and rationale of A Multicenter Paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock - The PANDA trial
Jason E Bloom, Jocasta Ball, Daniel Okyere, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
December 20, 2019
The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendations for Assessment of Suspected Acute Coronary Syndrome Using High-Sensitivity Cardiac Troponin T in the Emergency Department
Wei Chieh Jack Tan, Kenji Inoue, Laila AbdelWareth, et al.
The American Journal of Cardiology
|
April 28, 2004
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)
A Michael Lincoff, John A Bittl, Neal S Kleiman, et al.
The Medical Journal of Australia
|
August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement
Sarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
Page
of 26